PDS Biotechnology Corp
PDSB1.100USD
+0.010+0.92%
交易中 （美东）报价延迟15分钟
49.99M总市值
亏损市盈率 TTM
关于 PDS Biotechnology Corp 公司
PDS Biotechnology Corporation 是一家临床阶段的免疫疗法公司。该公司正在开发一系列靶向癌症免疫疗法，这些疗法基于其 Versamune T 细胞激活剂和 Versamune，以及其白介素 12 (IL-12) 融合抗体药物偶联物 (ADC)、PDS01ADC（一种肿瘤靶向免疫细胞因子）。PDS0101 是其基于 Versamune 的主要免疫疗法。PDS0101 将 Versamune 与源自致癌 HPV16 病毒蛋白的短蛋白 (肽) 混合物相结合。Versamune 是一种专有的脂质纳米颗粒和 T 细胞激活平台。PDS0301 是一种白介素 12 (IL-12) 的肿瘤靶向抗体偶联物，可增强肿瘤微环境中 T 细胞的增殖、效力、浸润和寿命。其 Versamune 免疫疗法和 Versamune 与 PDS01ADC 的组合用于肿瘤治疗，而 Infectimune 用于预防传染性病原体的疫苗。
公司简介
公司代码PDSB
公司名称PDS Biotechnology Corp
上市日期Oct 01, 2015
CEODr. Frank Bedu-Addo, Ph.D.
员工数量24
证券类型Ordinary Share
年结日Oct 01
公司地址303A College Road East
城市PRINCETON
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编08540
电话18002083343
网址https://www.pdsbiotech.com
公司代码PDSB
上市日期Oct 01, 2015
CEODr. Frank Bedu-Addo, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Frank Bedu-Addo, Ph.D.
Dr. Frank Bedu-Addo, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
690.87K
--
Mr. Stephen C. (Steve) Glover
Mr. Stephen C. (Steve) Glover
Independent Chairman of the Board
Independent Chairman of the Board
78.85K
--
Mr. Gregory Gene (Greg) Freitag, CPA., J.D.
Mr. Gregory Gene (Greg) Freitag, CPA., J.D.
Independent Director
Independent Director
61.21K
--
Ms. Kamil Ali-Jackson, Esq., J.D.
Ms. Kamil Ali-Jackson, Esq., J.D.
Independent Director
Independent Director
11.76K
--
Dr. Ilian Petkov Iliev
Dr. Ilian Petkov Iliev
Director
Director
--
--
Mr. Mike Moyer
Mr. Mike Moyer
IR Contact Officer
IR Contact Officer
--
--
Mr. Spencer Brown
Mr. Spencer Brown
Senior Vice President, Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Compliance Officer, General Counsel, Corporate Secretary
--
--
Mr. Stephan Toutain
Mr. Stephan Toutain
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kirk V. Shepard, M.D.
Dr. Kirk V. Shepard, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Otis W. Brawley, M.D.
Dr. Otis W. Brawley, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Frank Bedu-Addo, Ph.D.
Dr. Frank Bedu-Addo, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
690.87K
--
Mr. Stephen C. (Steve) Glover
Mr. Stephen C. (Steve) Glover
Independent Chairman of the Board
Independent Chairman of the Board
78.85K
--
Mr. Gregory Gene (Greg) Freitag, CPA., J.D.
Mr. Gregory Gene (Greg) Freitag, CPA., J.D.
Independent Director
Independent Director
61.21K
--
Ms. Kamil Ali-Jackson, Esq., J.D.
Ms. Kamil Ali-Jackson, Esq., J.D.
Independent Director
Independent Director
11.76K
--
Dr. Ilian Petkov Iliev
Dr. Ilian Petkov Iliev
Director
Director
--
--
Mr. Mike Moyer
Mr. Mike Moyer
IR Contact Officer
IR Contact Officer
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月26日 周六
更新时间: 7月26日 周六
持股股东
股东类型
持股股东
持股股东
占比
Armistice Capital LLC
9.67%
The Vanguard Group, Inc.
3.30%
Bedu-Addo (Frank)
1.51%
BlackRock Institutional Trust Company, N.A.
1.05%
Sykes (Richard)
0.97%
Other
83.49%
持股股东
持股股东
占比
Armistice Capital LLC
9.67%
The Vanguard Group, Inc.
3.30%
Bedu-Addo (Frank)
1.51%
BlackRock Institutional Trust Company, N.A.
1.05%
Sykes (Richard)
0.97%
Other
83.49%
股东类型
持股股东
占比
Hedge Fund
9.80%
Investment Advisor
6.01%
Individual Investor
3.09%
Investment Advisor/Hedge Fund
1.54%
Research Firm
0.71%
Pension Fund
0.04%
Bank and Trust
0.01%
Other
78.80%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
187
9.67M
21.15%
+1.28M
2025Q1
201
9.77M
22.08%
+1.54M
2024Q4
205
5.67M
12.73%
-3.40M
2024Q3
205
5.76M
15.58%
-3.85M
2024Q2
208
6.94M
18.83%
-4.50M
2024Q1
195
8.96M
25.12%
-3.13M
2023Q4
194
9.68M
31.15%
-1.91M
2023Q3
192
9.20M
29.70%
-3.29M
2023Q2
183
9.26M
30.03%
-1.73M
2023Q1
149
11.76M
39.00%
-275.25K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Armistice Capital LLC
4.42M
9.67%
+4.42M
--
Mar 31, 2025
The Vanguard Group, Inc.
1.51M
3.3%
+4.41K
+0.29%
Mar 31, 2025
Bedu-Addo (Frank)
690.87K
1.51%
--
--
Apr 17, 2025
BlackRock Institutional Trust Company, N.A.
480.97K
1.05%
-4.48K
-0.92%
Mar 31, 2025
Sykes (Richard)
445.11K
0.97%
--
--
Apr 17, 2025
Geode Capital Management, L.L.C.
437.88K
0.96%
+20.66K
+4.95%
Mar 31, 2025
William Blair & Company, L.L.C. (Research)
257.20K
0.56%
+99.70K
+63.30%
Mar 31, 2025
UBS Financial Services, Inc.
245.33K
0.54%
+221.67K
+936.97%
Mar 31, 2025
State Street Global Advisors (US)
133.33K
0.29%
--
--
Mar 31, 2025
Conn (Gregory L Ph.D.)
123.59K
0.27%
--
--
Apr 17, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Core Equity Market ETF
0%
Global X Russell 2000 ETF
0%
Avantis US Small Cap Equity ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 Covered Call ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.01%
DFA Dimensional US Core Equity Market ETF
占比0%
Global X Russell 2000 ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%
Proshares Ultra Russell 2000
占比0%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
iShares Russell 2000 ETF
占比0%
ProShares UltraPro Russell2000
占比0%
Global X Russell 2000 Covered Call ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
